Pharmacodynamics Flashcards

1
Q

pharmacology

A

study of drugs that interact with living beings through chemical processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pharmacodynamics

A

drugs acting on body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pharmacokinetics

A

body acting on drug (metabolism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

receptors

A

interacts with drug and initiates the biochemical events leading to effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

physiological receptor

A

receptor for something naturally made in body (muscarinic, adrenergic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

agonists

A

activate receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antagonists

A

block endogenous ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

negative or positive allosteric modulator

A

endogenous ligand to be weaker / stronger (bind somewhere else besides active site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

generalized receptors

A

not normally a receptor, drug binds to it and alters function (voltage-gated Na+ channels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do drugs bind to receptors?

A

hydrogen bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what can be drugs

A

anything that produces a physiological effect (most small molecules)

large amount of drugs deviate (biologics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ligand gated ion channels

A

channel opens (allow ions to pass) when signaling molecule binds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

G-protein coupled receptors

A

activates G protein with activate secondary messenger (cAMP) cascades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

enzyme-linked (receptor tyrosine kinase)

A

activates signaling cascades through phosphorylation of substrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nuclear receptor

A

steroid hormone are lipid soluble - allows to enter cell through lipid bilayer

activates or inhibits gene expression after binds to response elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

other receptors

A

no endogenous molecule acts on them, but affected by drugs

ex. proton pump, voltage gated ion channels, enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

physical properties of drug and structure determine (3 things)

A

binding
selectivity
affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

selectivity

A

1 or many receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

NOT ideal conditions of selectivity

A

bind to same receptor in multiple organs

bind to different receptors, especially when drug concentration in creases (more undesirable side effects)

20
Q

when are drugs more specific?

A

at low concentrations

21
Q

affinity

A

how readily and tightly does it bind

22
Q

high affinitiy

A

good drug receptor interaction, less drug needed to produce a response

23
Q

low affinity

A

poor drug receptor interaction, more drug needed to produce a response

24
Q

affinity is measured through

A

equilibrium dissociation constant (Kd)

25
equilibrium dissociation constant
drug concentration for which 50% of that receptor is bound by the drug
26
lower Kd
higher affinity
27
higher Kd
lower affinity
28
law of mass action
drug effects are reversible interactions - can tilt equilibrium
29
when drug receptor complex is activated
conformational change
30
potency
how much drug needed to produce certain effect
31
efficacy
how big is the effect
32
quantal dose response
yes or no situation
33
therapeutic index
want high, so likelihood of toxicity is not reachable
34
margin of safety
the higher the TI of MOS, the safer the drug
35
antagonists
bind to receptor but don't cause conformational change or biological response
36
competitive antagonist
more drug necessary to achieve effect (surmountable) -compete for active site but doesn't activate it -decrease in potency but no decrease in efficacy
37
noncompetitive antagonist
antagonist that bind covalently (insurmountable) -irreversibly bind to allosteroic site on receptor to prevent activation of receptor -decrease in efficacy
38
partial agonist
can't achieve 100% decrease effects of full agonist when given together
39
inverse agonists
promotes inactive conformation - produce opposite effects of regular agonists
40
allosteric modulators
bind to secondary, allosteric site to + or - regulate agonist binding / efficacy
41
orthosteric drugs
bind to primary agonist site on receptor (no effect on signalling)
42
tachyphylaxis
decrease response when same does is given repeatbly
43
desensitization
receptor phosphorylated and binds B-arrestin
44
inactivation
receptor removed from membrane (reversible) membrane forms endosome so receptor is embedded in it can lead to degradation
45
pharmacodynamic tolerance
chronic exposure to agonist can cause decrease in receptor number due to degradation of receptor or decrease in gene expression
46
upregulation
greater receptor number
47
REVIEW GRAPHS!!!